With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

West Pharmaceutical Servs's WST short percent of float has risen 12.9% since its last report. The company recently reported ...

Bristol-Myers Squibb awarded its CEO nearly $19 million in compensation for 2024, following a challenging year for the ...

Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) said March 28 it will exclusively license its drug candidate LX9581 to Danish ...

Rocket Lab (NASDAQ: RKLB) shareholders received some wonderful news Thursday night when the U.S. Department of Defense ...

Texas and New Mexico's health departments said on Friday measles cases in their states have risen to 444, an increase of 74 ...

Harrow, Inc. offers speculative gains from $20s to $30s, with Q4 growth, bullish 2025 revenue guidance, and long-term growth ...

Novo Nordisk has signed a deal worth up to $1bn with Lexicon Pharmaceuticals for the exclusive global rights to LX9851, an ...

Milestone Pharmaceuticals Inc.’s MIST share price has dipped by 61.33%, which has investors questioning if this is right time to buy.

Domestic benchmark indices ended higher 27 March, Thursday, with the Nifty 50 gaining 0.45%, rebounding from its 100-day ...

Results from the company’s Phase II trial also saw PL8177 elicit a clinical response in 77% of ulcerative colitis patients.

Rocket Lab shares climbed Friday after the U.S. Space Force selected the space rocket company to join its $5.6 billion ...